Aeterna Zentaris
AEZS
#10173
Rank
โ‚น1.59 B
Marketcap
โ‚น520.76
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -โ‚น170.14

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -โ‚น186.54. In 2022 the company made an earnings per share (EPS) of -โ‚น426.07 a decrease over its 2021 EPS that were of -โ‚น165.69.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น170.14
2022-โ‚น426.07157.14%
2021-โ‚น165.69-41.48%
2020-โ‚น283.14-64.46%
2019-โ‚น796.61-240%
2018โ‚น569.01-122.32%
2017-โ‚น2,549-53.53%
2016-โ‚น5,485-86.71%
2015-โ‚น41,287-35.21%
2014-โ‚น63,729-216.67%
2013โ‚น54,625-123.3%
2012-โ‚น2,34,431-40.8%
2011-โ‚น3,96,028-6.45%
2010-โ‚น4,23,340-27.91%
2009-โ‚น5,87,214-61.61%
2008-โ‚น15,29,48783.61%
2007-โ‚น8,33,024-195.31%
2006โ‚น8,73,993178.26%
2005โ‚น3,14,091-330%
2004-โ‚น1,36,561-80.05%
2003-โ‚น6,84,50817.78%
2002-โ‚น5,81,182515.93%
2001-โ‚น94,359-68.6%
2000-โ‚น3,00,535119.62%
1999-โ‚น1,36,841-3.63%
1998-โ‚น1,42,002

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น670.06-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น188.01-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น270.39-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น32.77-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น445.19-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA